Clinical Trial Update: Congenital Cytomegalovirus: Efficacy of Antiviral Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial update on antiviral treatment for congenital cytomegalovirus infection with sensorineural hearing loss; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Cytomegalovirus Infection
• Sensorineural Hearing Loss

Snippet

Sponsor: Dr. Ann C.T.M. Vossen | Conditions: Congenital Cytomegalovirus Infection, Sensorineural Hearing Loss | Phase 3 | Status: COMPLETED